Anyuan Pharmaceuticals
Anyuan Pharmaceutical Technology (Shanghai) develops biological macromolecular drugs.
$33.02M Strategic round ·
Led by North China Pharmaceutical Group Corporation · Source: ifastdata.com
Funding history ↓Signals
Website registeredMay 23, 2012 (14 years old)
Funding rounds
- Strategic round · $33.02MSource: ifastdata.com
- Website created
Investors
Companies like Anyuan Pharmaceuticals
EElement Biosciences$175M Series B+ · Jun 2026
CConverge Bio$25M Series A · Jan 2026
AAspect Analytics$11.73M Series A · Sep 2025
EElucidata$16M Series A · Sep 2022
VValenPre Seed · Apr 2026
TTargED BiopharmaceuticalsSeries A · Jul 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/anyuan-pharmaceuticals (get a free API key).